Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $52.5799 (-1.93%) ($52.4174 - $53.2895) on Fri. Nov. 7, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.62% (three month average) | RSI | 80 | Latest Price | $52.5799(-1.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.6% a day on average for past five trading days. | Weekly Trend | ABBV advances 4.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(62%) SPY(46%) VT(44%) XBI(41%) XLF(40%) | Factors Impacting ABBV price | ABBV will decline at least -0.81% in a week (0% probabilities). VIXM(-24%) TLT(-15%) UUP(-7%) IGOV(-4%) GLD(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.81% (StdDev 1.62%) | Hourly BBV | 0 () | Intraday Trend | -1.3% | | | |
|
5 Day Moving Average | $53.46(-1.65%) | 10 Day Moving Average | $52.93(-0.66%) | 20 Day Moving Average | $50.4(4.33%) | To recent high | -3.1% | To recent low | 18.2% | Market Cap | $92.766b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |